Cardiovascular Systems Inc (CSII):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cardiovascular Systems Inc (CSII) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6477
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company’s products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.

Cardiovascular Systems Inc (CSII) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cardiovascular Systems Inc, Medical Equipment, Deal Details 10
Partnerships 10
Cardiovascular Systems Enters into Co-Development Agreement with Aerolase 10
Cardiovascular Systems Enters into Distribution Agreement with OrbusNeich 11
Cardiovascular Systems Enters into Agreement with OrbusNeich 12
Cardiovascular Systems Enters into Distribution Agreement with Medikit 13
Equity Offering 14
Cardiovascular Systems Completes Public Offering Of Shares For US$101.7 Million 14
Cardiovascular Systems Completes Public Offering Of Shares For US$40.5 Million 16
Cardiovascular Systems Completes Public Offering Of Common Stock For US$16 Million 17
Cardiovascular Systems Inc – Key Competitors 19
Cardiovascular Systems Inc – Key Employees 20
Cardiovascular Systems Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Jul 30, 2018: Cardiovascular Systems Reports Fiscal 2018 Fourth-Quarter Financial Results 22
May 02, 2018: Cardiovascular Systems Reports Fiscal 2018 Third-Quarter Financial Results 24
Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results 26
Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results 28
Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 30
May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 32
Jan 25, 2017: Cardiovascular Systems Reports Fiscal 2017 Second-Quarter Financial Results 34
Corporate Communications 36
Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer 36
Jan 24, 2018: Cardiovascular Systems Appoints Rhonda Robb as New Chief Operating Officer 37
Feb 21, 2017: Cardiovascular Systems Announces Healthcare Veteran Martha Goldberg Aronson Joins Board of Directors 38
Other Significant Developments 39
Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Cardiovascular Systems Inc, Medical Equipment, Key Facts, 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Deals By Market, 2012 to YTD 2018 8
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cardiovascular Systems Enters into Co-Development Agreement with Aerolase 10
Cardiovascular Systems Enters into Distribution Agreement with OrbusNeich 11
Cardiovascular Systems Enters into Agreement with OrbusNeich 12
Cardiovascular Systems Enters into Distribution Agreement with Medikit 13
Cardiovascular Systems Completes Public Offering Of Shares For US$101.7 Million 14
Cardiovascular Systems Completes Public Offering Of Shares For US$40.5 Million 16
Cardiovascular Systems Completes Public Offering Of Common Stock For US$16 Million 17
Cardiovascular Systems Inc, Key Competitors 19
Cardiovascular Systems Inc, Key Employees 20

List of Figures
Cardiovascular Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cardiovascular Systems Inc (CSII):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CP All Public Company Ltd (CPALL):企業の財務・戦略的SWOT分析
    CP All Public Company Ltd (CPALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析
    Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Malee Group Public Company Limited:企業の戦略・SWOT・財務分析
    Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • WorleyParsons Limited:企業の戦略・SWOT・財務情報
    WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report Summary WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Phosphagenics Ltd:企業の戦略・SWOT・財務情報
    Phosphagenics Ltd - Strategy, SWOT and Corporate Finance Report Summary Phosphagenics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cisco Systems, Inc (CSCO)-石油・ガス分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Transaero, Inc.:企業の戦略・SWOT・財務情報
    Transaero, Inc. - Strategy, SWOT and Corporate Finance Report Summary Transaero, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Handok Inc (002390):医療機器:M&Aディール及び事業提携情報
    Summary Handok Inc (Handok), formerly Handok Pharmaceuticals Co Ltd is a pharmaceutical and health care company that manufactures, develops, and distributes healthcare solutions. The company develops and provides pharmaceutical products such as OTC drugs, medical devices, prescription drugs and in v …
  • Telenor ASA:企業の戦略・SWOT・財務分析
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CareDx Inc (CDNA):企業の財務・戦略的SWOT分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • AxoGen Inc (AXGN):企業の財務・戦略的SWOT分析
    Summary AxoGen Inc (AxoGen) formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company's products include AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among other …
  • Rockhopper Exploration PLC (RKH):企業の財務・戦略的SWOT分析
    Summary Rockhopper Exploration Plc (Rockhopper Exploration) is an oil and gas company that acquires, explores and produces crude oil and natural gas properties in the Falkland Islands and the Greater Mediterranean region. The company’s portfolio of production licenses includes PL003a, PL003b, PL004a …
  • First American Financial Corp:企業の戦略・SWOT・財務情報
    First American Financial Corp - Strategy, SWOT and Corporate Finance Report Summary First American Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Enero Group Limited (EGG):企業の財務・戦略的SWOT分析
    Enero Group Limited (EGG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BioCision LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary BioCision LLC (BioCision) is a life science research and development company that develops products and solutions for process standardization. The company provides products such as cell cryopreservation systems, ice-free cooling systems, tube and plate temperature management systems, cell th …
  • Manhattan Beer Distributors:企業の戦略・SWOT・財務情報
    Manhattan Beer Distributors - Strategy, SWOT and Corporate Finance Report Summary Manhattan Beer Distributors - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • H. Lee Moffitt Cancer Center & Research Institute Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such a …
  • Sto SE & Co KGaA:企業の戦略・SWOT・財務情報
    Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PCCW Limited:企業の戦略・SWOT・財務情報
    PCCW Limited - Strategy, SWOT and Corporate Finance Report Summary PCCW Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • HPQ Silicon Resources Inc (HPQ):企業の財務・戦略的SWOT分析
    Summary HPQ Silicon Resources Inc (HPQ Silicon), formerly Uragold Bay Resources, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, production and development of silicon, gold and quartz properties, among others. It holds interests in The B …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆